Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature, Diseases | 3 | 2022 | 46 | 1.670 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2020 | 14 | 1.340 |
Why?
|
| Infant, Premature | 6 | 2024 | 174 | 1.330 |
Why?
|
| Infant, Newborn | 13 | 2024 | 1307 | 1.170 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2022 | 33 | 1.010 |
Why?
|
| Intestinal Perforation | 1 | 2022 | 14 | 0.840 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2022 | 16 | 0.830 |
Why?
|
| Indomethacin | 2 | 2020 | 20 | 0.820 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2024 | 164 | 0.800 |
Why?
|
| Acetaminophen | 2 | 2020 | 52 | 0.790 |
Why?
|
| Retinopathy of Prematurity | 1 | 2022 | 10 | 0.790 |
Why?
|
| Delivery Rooms | 1 | 2021 | 2 | 0.770 |
Why?
|
| Hyperoxia | 2 | 2017 | 16 | 0.720 |
Why?
|
| Lung Injury | 2 | 2018 | 31 | 0.720 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2019 | 43 | 0.640 |
Why?
|
| Lung | 3 | 2018 | 821 | 0.620 |
Why?
|
| Hemangioma | 1 | 2018 | 27 | 0.610 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2017 | 27 | 0.600 |
Why?
|
| Infant | 6 | 2022 | 1518 | 0.590 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2017 | 4 | 0.590 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 84 | 0.550 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 157 | 0.510 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 275 | 0.500 |
Why?
|
| Infant, Extremely Premature | 2 | 2024 | 36 | 0.390 |
Why?
|
| Pregnancy | 6 | 2024 | 2348 | 0.350 |
Why?
|
| Prospective Studies | 3 | 2022 | 3080 | 0.350 |
Why?
|
| Retrospective Studies | 5 | 2024 | 5951 | 0.280 |
Why?
|
| Infant, Low Birth Weight | 3 | 2022 | 58 | 0.270 |
Why?
|
| Humans | 15 | 2024 | 59068 | 0.260 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2024 | 35 | 0.250 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2024 | 9 | 0.230 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2021 | 71 | 0.230 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2024 | 73 | 0.220 |
Why?
|
| Inflammasomes | 2 | 2017 | 322 | 0.220 |
Why?
|
| Psychotropic Drugs | 1 | 2024 | 83 | 0.210 |
Why?
|
| Seizures | 1 | 2024 | 117 | 0.210 |
Why?
|
| Animals, Newborn | 3 | 2018 | 229 | 0.210 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2022 | 39 | 0.190 |
Why?
|
| Tidal Volume | 1 | 2021 | 34 | 0.190 |
Why?
|
| Female | 9 | 2024 | 30700 | 0.190 |
Why?
|
| Positive-Pressure Respiration | 1 | 2021 | 45 | 0.190 |
Why?
|
| Vascular Remodeling | 2 | 2018 | 23 | 0.180 |
Why?
|
| Hypertrophy, Right Ventricular | 2 | 2017 | 7 | 0.180 |
Why?
|
| Delivery, Obstetric | 1 | 2021 | 55 | 0.180 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 62 | 0.180 |
Why?
|
| Pyrimidines | 2 | 2018 | 123 | 0.180 |
Why?
|
| Hypertension, Pulmonary | 2 | 2018 | 77 | 0.180 |
Why?
|
| Breast Feeding | 1 | 2022 | 138 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 701 | 0.170 |
Why?
|
| Male | 7 | 2024 | 27390 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2018 | 569 | 0.160 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 187 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2021 | 519 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 25 | 0.150 |
Why?
|
| Conservative Treatment | 1 | 2018 | 13 | 0.150 |
Why?
|
| Pyrazoles | 1 | 2018 | 73 | 0.150 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 53 | 0.150 |
Why?
|
| Child, Preschool | 1 | 2022 | 1823 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2018 | 147 | 0.140 |
Why?
|
| Quality of Life | 1 | 2024 | 1103 | 0.140 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2016 | 16 | 0.140 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 61 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 102 | 0.140 |
Why?
|
| Child | 2 | 2024 | 4259 | 0.140 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 261 | 0.120 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 691 | 0.120 |
Why?
|
| Pneumonia | 1 | 2017 | 263 | 0.120 |
Why?
|
| Parenteral Nutrition | 1 | 2013 | 21 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 2052 | 0.110 |
Why?
|
| Growth Disorders | 1 | 2013 | 30 | 0.110 |
Why?
|
| Enteral Nutrition | 1 | 2013 | 55 | 0.100 |
Why?
|
| Nutritional Status | 1 | 2013 | 118 | 0.100 |
Why?
|
| Gestational Age | 2 | 2024 | 182 | 0.100 |
Why?
|
| Adolescent | 1 | 2022 | 5896 | 0.100 |
Why?
|
| Macrophages | 1 | 2017 | 1003 | 0.100 |
Why?
|
| Body Weight | 1 | 2013 | 378 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 782 | 0.090 |
Why?
|
| Honey | 1 | 2009 | 1 | 0.090 |
Why?
|
| Time Factors | 1 | 2017 | 3554 | 0.090 |
Why?
|
| Toxins, Biological | 1 | 2009 | 6 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2022 | 0.080 |
Why?
|
| Pandemics | 2 | 2022 | 603 | 0.070 |
Why?
|
| Animals | 3 | 2018 | 19552 | 0.060 |
Why?
|
| Patient Discharge | 2 | 2022 | 477 | 0.060 |
Why?
|
| Maternal Health | 1 | 2024 | 13 | 0.060 |
Why?
|
| Maternal Age | 1 | 2024 | 34 | 0.060 |
Why?
|
| Pulmonary Surfactants | 1 | 2024 | 9 | 0.060 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2024 | 27 | 0.060 |
Why?
|
| Rats | 2 | 2018 | 1904 | 0.060 |
Why?
|
| Social Class | 1 | 2024 | 123 | 0.060 |
Why?
|
| New England | 1 | 2024 | 267 | 0.050 |
Why?
|
| Aftercare | 1 | 2022 | 66 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2024 | 925 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2024 | 285 | 0.050 |
Why?
|
| Premature Birth | 1 | 2021 | 106 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 188 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 373 | 0.040 |
Why?
|
| Adult | 3 | 2024 | 15677 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 39 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 2018 | 28 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2018 | 43 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 709 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 33 | 0.040 |
Why?
|
| Aminoquinolines | 1 | 2016 | 15 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 220 | 0.030 |
Why?
|
| Massachusetts | 1 | 2021 | 2082 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 1 | 2013 | 9 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2013 | 30 | 0.030 |
Why?
|
| Dietary Proteins | 1 | 2013 | 54 | 0.030 |
Why?
|
| Birth Weight | 1 | 2013 | 83 | 0.030 |
Why?
|
| Risk Factors | 1 | 2021 | 4989 | 0.020 |
Why?
|
| Rhododendron | 1 | 2009 | 1 | 0.020 |
Why?
|
| Young Adult | 1 | 2009 | 4301 | 0.010 |
Why?
|